Log in
Enquire now
‌

US Patent 10093915 Histidyl-tRNA synthetase-Fc conjugates

Patent 10093915 was granted and assigned to aTyr Pharma on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
aTyr Pharma
aTyr Pharma
Date Filed
January 25, 2017
Date of Patent
October 9, 2018
Patent Applicant
aTyr Pharma
aTyr Pharma
Patent Application Number
15415369
Patent Citations Received
‌
US Patent 11976084 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 10526419 Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
‌
US Patent 10711260 Histidyl-tRNA synthetase-Fc conjugates
0
‌
US Patent 10941214 Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
‌
US Patent 11072787 Histidyl-tRNA synthetase-Fc conjugates
‌
US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents
0
‌
US Patent 11325916 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11339170 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 11767520 Compositions and methods for treating lung inflammation
‌
US Patent 11352363 Spiropyrrolidine derived antiviral agents
0
•••
Patent Inventor Names
Chi-Fang Wu
0
Marc Thomas
0
Minh-Ha Do
0
Ying Buechler
0
Darin Lee
0
Jeffry D. Watkins
0
John D. Mendlein
0
Kristi Piehl
0
Kyle P. Chiang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10093915
Patent Primary Examiner
‌
Kagnew H Gebreyesus

Find more entities like US Patent 10093915 Histidyl-tRNA synthetase-Fc conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.